Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Develops inhaled therapies for severe respiratory diseases
Pitching Schroders Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room